J M Wardlaw1, R Offin, G M Teasdale, E M Teasdale. 1. Department of Neuroradiology, Institute of Neurological Sciences, Southern General Hospital, Glasgow, United Kingdom. jmw@skull.dcn.ed.ac.uk
Abstract
OBJECT: In this prospective observational study, the authors assess the impact of routine transcranial Doppler (TCD) ultrasound monitoring on the diagnosis, management, and outcome of delayed ischemic neurological deficit complicating subarachnoid hemorrhage (SAH). METHODS: Over a 10-month period 186 patients admitted to a regional neurosciences center were included in the study. Three times a week, routine TCD examinations performed by neuroradiographers made an important positive contribution to the diagnosis of delayed ischemic neurological deficit in 72% of patients with this complication and led to altered management for the benefit of the patient in 43%. In 9% of patients with recent SAH, it was believed that the outcome might have been better if the TCD result had been acted upon appropriately. The TCD results did not adversely influence management or outcome and were generally accurate when compared with those obtained on angiography. CONCLUSIONS: A routine TCD service provided by neuroradiographers is accurate and useful in diagnosing and managing elevated blood velocities and ischemic neurological deficit following SAH. In addition, it is possible that if the information gleaned from TCD findings was used more often in patient management, outcome might be improved; however, a randomized controlled trial is necessary to assess both these points definitively.
OBJECT: In this prospective observational study, the authors assess the impact of routine transcranial Doppler (TCD) ultrasound monitoring on the diagnosis, management, and outcome of delayed ischemic neurological deficit complicating subarachnoid hemorrhage (SAH). METHODS: Over a 10-month period 186 patients admitted to a regional neurosciences center were included in the study. Three times a week, routine TCD examinations performed by neuroradiographers made an important positive contribution to the diagnosis of delayed ischemic neurological deficit in 72% of patients with this complication and led to altered management for the benefit of the patient in 43%. In 9% of patients with recent SAH, it was believed that the outcome might have been better if the TCD result had been acted upon appropriately. The TCD results did not adversely influence management or outcome and were generally accurate when compared with those obtained on angiography. CONCLUSIONS: A routine TCD service provided by neuroradiographers is accurate and useful in diagnosing and managing elevated blood velocities and ischemic neurological deficit following SAH. In addition, it is possible that if the information gleaned from TCD findings was used more often in patient management, outcome might be improved; however, a randomized controlled trial is necessary to assess both these points definitively.
Authors: Franck Amyot; David B Arciniegas; Michael P Brazaitis; Kenneth C Curley; Ramon Diaz-Arrastia; Amir Gandjbakhche; Peter Herscovitch; Sidney R Hinds; Geoffrey T Manley; Anthony Pacifico; Alexander Razumovsky; Jason Riley; Wanda Salzer; Robert Shih; James G Smirniotopoulos; Derek Stocker Journal: J Neurotrauma Date: 2015-09-30 Impact factor: 5.269
Authors: Andreas R Luft; Manuel M Buitrago; Michel Torbey; Anish Bhardwaj; Alexander Razumovsky Journal: Neurocrit Care Date: 2004 Impact factor: 3.210
Authors: T E Darsaut; M B Keough; A M Chan; B Farzin; J M Findlay; M M Chow; M Chagnon; J Zehr; G Gevry; J Raymond Journal: AJNR Am J Neuroradiol Date: 2021-11-18 Impact factor: 3.825
Authors: L Mascia; L Fedorko; K terBrugge; C Filippini; M Pizzio; V M Ranieri; M C Wallace Journal: Intensive Care Med Date: 2003-05-28 Impact factor: 17.440
Authors: S Binaghi; M L Colleoni; P Maeder; A Uské; L Regli; A Reza Dehdashti; P Schnyder; R Meuli Journal: AJNR Am J Neuroradiol Date: 2007-04 Impact factor: 3.825
Authors: Gyanendra Kumar; Oana M Dumitrascu; Chia-Chun Chiang; Cumara B O'Carroll; Andrei V Alexandrov Journal: Neurocrit Care Date: 2019-02 Impact factor: 3.210
Authors: J Joep van der Harst; Gert-Jan R Luijckx; Jan Willem J Elting; Reinoud P H Bokkers; Walter M van den Bergh; Omid S Eshghi; Jan D M Metzemaekers; Rob J M Groen; Aryan Mazuri; J Marc C van Dijk; Maarten Uyttenboogaart Journal: Crit Care Explor Date: 2019-01-01